News
By Sriparna Roy (Reuters) -Regeneron shares fell 9% before the bell on Friday after its experimental drug for patients with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback